Breaking News

You are here » Indian-Commodity  :  Top News  :  EMCO to sell solar business to its subsidiary company


EMCO to sell solar business to its subsidiary company

EMCO has received an approval for sale and transfer of entire 5 MWp Solar Business of the company to its wholly owned subsidiary -- EMCO Infrastructure on slump sale basis. The Board of Directors of the company at their meeting held on August 09, 2018, approved the same.

The lump sum equity consideration would be not more than Rs 15 crore. EMCO Infrastructure is primarily incorporated for power generation, transmission and allied business through renewable energy.

EMCO is engaged in manufacturing power equipment's and is the third largest manufacturer of transformers in India. The company has also diversified their business by manufacturing electronic energy meters EMCO provides innovative technologies, solutions, products and services to a wide range of customers in the transmission and distribution sector. 

Related News

View all news

Crude oil futures end higher on Friday

Crude oil futures ended higher on Friday on worries about possible impact of US sanctions on Iran's oil exports on crude supply in the market coupled with potential US-Saudi tensions. Prices also supported......

Crude oil futures extend losses on Thursday

Extending previous session losses, crude oil futures ended lower on Thursday due to a sharp jump in US crude inventories last week and on demand growth concerns. The Energy Information Administration's......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......